MedPath

Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

Phase 2
Conditions
Major Depressive Disorder
Interventions
Registration Number
NCT06423781
Lead Sponsor
Biohaven Therapeutics Ltd.
Brief Summary

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
480
Inclusion Criteria
  1. Eligible subjects should have successfully completed the Treatment/Randomization Phase of parent studies.
  2. WOCBP must have a negative urine pregnancy test at Baseline Visit.
  3. WOCBP must not be breastfeeding or lactating at Baseline Visit or at any point during the study.

Key

Exclusion Criteria
  1. Any medical condition, based on the judgement of the Investigator, that would confound the ability to adequately assess safety and efficacy outcome measures.
  2. Participant non-compliance with study procedures, study drug or visit attendance in the parent study that the Investigator deems as clinically significant or unacceptable risk potential for this study.
  3. Investigator deems participant at imminent risk of danger to others.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
BHV-7000BHV-7000-
Primary Outcome Measures
NameTimeMethod
Number of Participants With Serious AEs (SAEs), AEs Leading to Study Drug Discontinuation, and AEs judged to be related to study medicationUp to 52 weeks

Safety and tolerability of BHV-7000 as assessed by frequency of unique subjects with SAEs; AEs leading to discontinuation; AEs judged to be related to study medication

Number of Participants With Clinically Significant Laboratory AbnormalitiesUp to 52 weeks

To assess the safety and tolerability of BHV-7000. This objective will be measured by assessing the number of unique subjects with grade 3 or 4 laboratory abnormalities.

Number of Participants With Vital Sign AbnormalitiesUp to 52 weeks
Number of Participants With Electrocardiogram (ECG) Abnormalities specific to QTc elevationUp to 52 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (64)

Reverie Mind, LLC

🇺🇸

Chandler, Arizona, United States

IMA Clinical Research

🇺🇸

Las Vegas, Nevada, United States

Pillar Clinical Research, LLC

🇺🇸

Little Rock, Arkansas, United States

WIRG

🇺🇸

Little Rock, Arkansas, United States

WRN

🇺🇸

Rogers, Arkansas, United States

Advanced Research Center, Inc.

🇺🇸

Anaheim, California, United States

CIT LA

🇺🇸

Bellflower, California, United States

IPMG

🇺🇸

Chino, California, United States

WR-PRI Encino

🇺🇸

Encino, California, United States

Collaborative Neuroscience Research, LLC (CenExel - CNS)

🇺🇸

Garden Grove, California, United States

CalNeuro Research Group

🇺🇸

Los Angeles, California, United States

Excell Research, Inc.

🇺🇸

Oceanside, California, United States

NRC Research Institute

🇺🇸

Orange, California, United States

Anderson Clinical Research

🇺🇸

Redlands, California, United States

CIT IE

🇺🇸

Riverside, California, United States

Lumos Clinical Research Center, LLC

🇺🇸

San Jose, California, United States

Clinical Neuroscience Solutions, Inc.

🇺🇸

Orlando, Florida, United States

DelRicht Research

🇺🇸

New Orleans, Louisiana, United States

Headlands Pharmasite

🇺🇸

Baltimore, Maryland, United States

Center for Emotional Fitness

🇺🇸

Cherry Hill, New Jersey, United States

SPRI Clinical Trials, LLC

🇺🇸

Brooklyn, New York, United States

Berman Clinical

🇺🇸

New York, New York, United States

FutureSearch Trials of Dallas

🇺🇸

Dallas, Texas, United States

Relaro Medical Trials, LLC

🇺🇸

Dallas, Texas, United States

Stanford

🇺🇸

Stanford, California, United States

Cenexel CNS

🇺🇸

Torrance, California, United States

Sunwise Clinical Research

🇺🇸

Walnut Creek, California, United States

Clinical Neuroscience Solutions, Inc

🇺🇸

Jacksonville, Florida, United States

Floridian Neuroscience Institute

🇺🇸

Miami Lakes, Florida, United States

K2 Medical Research

🇺🇸

Tampa, Florida, United States

Uptown Research Institute

🇺🇸

Chicago, Illinois, United States

Collective Medical Research

🇺🇸

Overland Park, Kansas, United States

Boston Clinical Trials

🇺🇸

Boston, Massachusetts, United States

Adams Clinical

🇺🇸

Watertown, Massachusetts, United States

Bio Behavioral Health

🇺🇸

Toms River, New Jersey, United States

RBA

🇺🇸

Staten Island, New York, United States

Midwest Clinical Research Center

🇺🇸

Dayton, Ohio, United States

Summit Headlands LLC

🇺🇸

Portland, Oregon, United States

Suburban Research Associates

🇺🇸

Media, Pennsylvania, United States

Scranton Medical Institute

🇺🇸

Moosic, Pennsylvania, United States

Pacific Clinical Research Management Group

🇺🇸

Upland, California, United States

MCB Clinical Research Centers

🇺🇸

Colorado Springs, Colorado, United States

Optum Behavioral Care of Connecticut, PC dba Comprehensive Psychiatric Care of Connecticut

🇺🇸

Norwich, Connecticut, United States

Neuroscience Research Institute

🇺🇸

West Palm Beach, Florida, United States

CenExel iResearch, LLC

🇺🇸

Savannah, Georgia, United States

Revive Research Institute, Inc.

🇺🇸

Elgin, Illinois, United States

Copley Clinical

🇺🇸

Boston, Massachusetts, United States

Precise Clinical Research

🇺🇸

Flowood, Mississippi, United States

Icahn School of Medicine at Mount Sinai

🇺🇸

New York, New York, United States

UConn Health

🇺🇸

Farmington, Connecticut, United States

CBH Health

🇺🇸

Gaithersburg, Maryland, United States

Arch Clinical Trials

🇺🇸

Saint Louis, Missouri, United States

Neurobehavioral Research, Inc

🇺🇸

Cedarhurst, New York, United States

Bioscience Research LLC

🇺🇸

Mount Kisco, New York, United States

The Medical Research Network, LLC

🇺🇸

New York, New York, United States

Lehigh Center for Clinical Research

🇺🇸

Allentown, Pennsylvania, United States

Coastal Carolina Research Center

🇺🇸

North Charleston, South Carolina, United States

Donald J. Garcia, MD, PA dba Austin Clinical Trial Partners

🇺🇸

Austin, Texas, United States

InSite Clinical Research, LLC

🇺🇸

DeSoto, Texas, United States

Red Oak Psychiatry Associates, PA

🇺🇸

Houston, Texas, United States

Aim Trials

🇺🇸

Plano, Texas, United States

Grayline Research Center

🇺🇸

Wichita Falls, Texas, United States

Alpine Reseach Organization

🇺🇸

Clinton, Utah, United States

Northwest Clinical Research Center

🇺🇸

Bellevue, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath